node1	node2	edge_score	
DB00999	CA2	1.0	
DB00999	SLC22A6	1.0	
DB00999	CA1	1.0	
DB00999	SLC12A3	1.0	
DB00999	KCNMA1	1.0	
complex:lAo9+jzjVOaRJSWZQvoh0G1mUDc	OR8D2	0.863824739585
KCNMA1	complex:lAo9+jzjVOaRJSWZQvoh0G1mUDc	0.904977499353
complex:lAo9+jzjVOaRJSWZQvoh0G1mUDc	KRT9	0.863824739585
complex:lAo9+jzjVOaRJSWZQvoh0G1mUDc	ALB	0.863824739585
SLC12A3		1.0
KCNMA1		1.0
Tubulointerstitial nephritis	ALB	1.0	
Tubulointerstitial nephritis	SLC12A3	1.0	
Essential hypertension	ALB	1.0	
Essential hypertension	KCNMA1	1.0	
Essential hypertension	SLC12A3	1.0	
Primary hyperaldosteronism	KCNMA1	1.0	
Primary hyperaldosteronism	SLC12A3	1.0	
Epilepsy	ALB	1.0	
Epilepsy	KCNMA1	1.0	
Epilepsy	SLC12A3	1.0	
Familial hypokalemia-hypomagnesemia	SLC12A3	1.0	
Malignant neoplasm of adrenal cortex	ALB	1.0	
Stage 5 chronic kidney disease	ALB	1.0	
Stage 5 chronic kidney disease	SLC12A3	1.0	
Esophageal varix	ALB	1.0	
Treacher Collins syndrome	SLC12A3	1.0	
Urolithiasis	ALB	1.0	
Adenocarcinoma of lung	ALB	1.0	
Adenocarcinoma of lung	KCNMA1	1.0	
Adenocarcinoma of lung	SLC12A3	1.0	
Echinococcosis	ALB	1.0	
Epidermolysis bullosa simplex, Cockayne-Touraine type	KRT9	1.0	
Palmar hyperkeratosis	KRT9	1.0	
Bladder neck obstruction	KCNMA1	1.0	
Proliferative retinopathy	ALB	1.0	
Chondrocalcinosis	SLC12A3	1.0	
Verrucae	KRT9	1.0	
Isolated somatotropin deficiency	ALB	1.0	
Renal tubular acidosis, distal, autosomal dominant	KCNMA1	1.0	
Substance Use Disorders	ALB	1.0	
Dentatorubral pallidoluysian atrophy	ALB	1.0	
Angiokeratoma	ALB	1.0	
Metabolic Bone Disorder	KCNMA1	1.0	
Isolated growth hormone deficiency type 1B	ALB	1.0	
Plantar hyperkeratosis	KRT9	1.0	
Abnormal urine output	SLC12A3	1.0	
Diabetic Retinopathy	ALB	1.0	
Diabetic Retinopathy	SLC12A3	1.0	
Pericardial effusion	ALB	1.0	
Hypervolemia	SLC12A3	1.0	
Germinoma	SLC12A3	1.0	
Abnormal drinking behavior	SLC12A3	1.0	
Mumps	ALB	1.0	
Rhinitis, Allergic, Perennial	ALB	1.0	
Endemic Cretinism	ALB	1.0	
Abnormality of renal excretion	SLC12A3	1.0	
Complete trisomy 18 syndrome	KCNMA1	1.0	
Hemangioblastoma	ALB	1.0	
Noonan syndrome with multiple lentigines	SLC12A3	1.0	
Mesangiocapillary glomerulonephritis, type II	ALB	1.0	
Nephrosclerosis	ALB	1.0	
Peripheral motor neuropathy	ALB	1.0	
End Stage Liver Disease	ALB	1.0	
Alkalosis	SLC12A3	1.0	
Polyuria	SLC12A3	1.0	
Abnormal albumin level	ALB	1.0	
Bronchogenic Carcinoma	ALB	1.0	
Dialeptic seizures	KCNMA1	1.0	
{TSC2 angiomyolipomas, renal, modifier of}, 613254 (3)	SLC12A3	1.0	
Coronary artery aneurysm	ALB	1.0	
Hyperlipoproteinemia	ALB	1.0	
Hyperlipoproteinemia Type IIa	ALB	1.0	
Single tumor	ALB	1.0	
Nephrotic Syndrome, Minimal Change	ALB	1.0	
Abnormality of potassium homeostasis	SLC12A3	1.0	
Skin Diseases, Genetic	KRT9	1.0	
Carcinoma breast stage IV	ALB	1.0	
Carcinoma breast stage IV	KCNMA1	1.0	
Varicella zoster	ALB	1.0	
Drusen	ALB	1.0	
Hypokalemia	SLC12A3	1.0	
Increased antibody level in blood	KRT9	1.0	
Insulin resistance syndrome	ALB	1.0	
Polydipsia	SLC12A3	1.0	
Nephrosis	ALB	1.0	
EEG with generalized epileptiform discharges	KCNMA1	1.0	
Renal Insufficiency, Chronic	ALB	1.0	
Renal Insufficiency, Chronic	SLC12A3	1.0	
Guillain-Barre syndrome, familial	ALB	1.0	
Abnormality of urine calcium concentration	SLC12A3	1.0	
Primary hyperparathyroidism	ALB	1.0	
Drug Resistant Epilepsy	ALB	1.0	
Respiratory Tract Diseases	ALB	1.0	
Sicca Syndrome	ALB	1.0	
Hypoalbuminemia	ALB	1.0	
Toxic Shock Syndrome	KCNMA1	1.0	
Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset	ALB	1.0	
Abnormality of the plantar skin of foot	KRT9	1.0	
Lymphangiomyomatosis	SLC12A3	1.0	
EEG with irregular generalized spike and wave complexes	KCNMA1	1.0	
Abnormality of monovalent inorganic cation homeostasis	SLC12A3	1.0	
Congenital hypothyroidism	ALB	1.0	
Adverse drug events and drug allergies	ALB	1.0	
Cortical dysplasia, complex, with other brain malformations 3	SLC12A3	1.0	
Aortic valve disease 2	SLC12A3	1.0	
Multisystem disorder	SLC12A3	1.0	
Vascular Diseases	ALB	1.0	
Vascular Diseases	SLC12A3	1.0	
Diaphragmatic hernia	KCNMA1	1.0	
Renal tubular dysfunction	SLC12A3	1.0	
Ovarian Serous Adenocarcinoma	KCNMA1	1.0	
Hemolytic uremic syndrome	ALB	1.0	
Bicuspid aortic valve	SLC12A3	1.0	
Occupational Diseases	ALB	1.0	
Microalbuminuria	ALB	1.0	
Chest pain	ALB	1.0	
Epilepsy, generalized, with febrile seizures plus, type 6 (2)	KCNMA1	1.0	
 {HIV-1 viremia, susceptibility to}, 609423 (3)	ALB	1.0	
Acute Lung Injury	ALB	1.0	
Generalized muscle weakness	SLC12A3	1.0	
Hirschsprung disease 1	SLC12A3	1.0	
Abnormal consumption behavior	SLC12A3	1.0	
Complications of Diabetes Mellitus	ALB	1.0	
Eczema	ALB	1.0	
Eczema	KRT9	1.0	
Hypercalciuria	SLC12A3	1.0	
Nephrocalcinosis	SLC12A3	1.0	
Pulmonary edema	ALB	1.0	
Epithelial hyperplasia of skin	SLC12A3	1.0	
Stevens-Johnson Syndrome	ALB	1.0	
Lymphohistiocytosis, Hemophagocytic	ALB	1.0	
Renal cell carcinoma, nonpapillary	ALB	1.0	
Renal cell carcinoma, nonpapillary	KCNMA1	1.0	
Renal cell carcinoma, nonpapillary	SLC12A3	1.0	
Absence seizures	KCNMA1	1.0	
IMMUNE SUPPRESSION	ALB	1.0	
Increased analgesia from kappa-opioid receptor agonist, female-specific	SLC12A3	1.0	
Juvenile onset	SLC12A3	1.0	
Chordoma	SLC12A3	1.0	
Dementia, Vascular	ALB	1.0	
Membranous nephropathy, susceptibility to	ALB	1.0	
DiGeorge sequence	ALB	1.0	
Muscle cramps	SLC12A3	1.0	
Liver regeneration disorder	ALB	1.0	
Diabetic Angiopathies	ALB	1.0	
Plasmacytoma	ALB	1.0	
Type 1 diabetic neuropathy	ALB	1.0	
Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	ALB	1.0	
Paralysis	SLC12A3	1.0	
Seizures, Febrile	ALB	1.0	
Seizures, Febrile	KCNMA1	1.0	
Seizures, Febrile	SLC12A3	1.0	
Hyperlipidemia, familial combined	ALB	1.0	
Generalized tonic-clonic seizures	KCNMA1	1.0	
Paresthesia	SLC12A3	1.0	
Interstitial fibrosis	ALB	1.0	
Abnormal urinary electrolyte concentration	SLC12A3	1.0	
Hemochromatosis	ALB	1.0	
Constitutional symptom	ALB	1.0	
Constitutional symptom	SLC12A3	1.0	
Abnormality of metabolism/homeostasis	ALB	1.0	
Abnormality of metabolism/homeostasis	KRT9	1.0	
Abnormality of metabolism/homeostasis	SLC12A3	1.0	
Hyperhidrosis	KRT9	1.0	
Methamphetamine abuse	ALB	1.0	
Hereditary factor VIII deficiency disease	ALB	1.0	
Lethargy	KCNMA1	1.0	
NOONAN-LIKE/MULTIPLE GIANT CELL LESION SYNDROME (disorder)	SLC12A3	1.0	
Hamartoma	SLC12A3	1.0	
Hypertension	ALB	1.0	
Hypertension	KCNMA1	1.0	
Hypertension	SLC12A3	1.0	
Fibrinogen Adverse Event	KCNMA1	1.0	
Abnormality of calcium homeostasis	SLC12A3	1.0	
Chorea, childhood-onset, with psychomotor retardation	KCNMA1	1.0	
Glomerulosclerosis, Focal Segmental	ALB	1.0	
tumor vasculature	ALB	1.0	
Diabetic Nephropathies	ALB	1.0	
Diabetic Nephropathies	SLC12A3	1.0	
Kidney Failure, Chronic	ALB	1.0	
Kidney Failure, Chronic	SLC12A3	1.0	
Maturity-onset diabetes of the young, type 11	ALB	1.0	
Pain	ALB	1.0	
Pain	SLC12A3	1.0	
Abnormality of divalent inorganic cation homeostasis	SLC12A3	1.0	
Osteoporosis	ALB	1.0	
Osteoporosis	SLC12A3	1.0	
Ischemia	ALB	1.0	
Ischemia	KCNMA1	1.0	
Focal segmental glomerulosclerosis	ALB	1.0	
Malnutrition	ALB	1.0	
Erythema	KRT9	1.0	
Tauopathies	SLC12A3	1.0	
Urticaria	ALB	1.0	
Thrombophilia	ALB	1.0	
Brain neoplasm	ALB	1.0	
Brain neoplasm	SLC12A3	1.0	
Impotence	KCNMA1	1.0	
EMG: myopathic abnormalities	KCNMA1	1.0	
EMG: myopathic abnormalities	SLC12A3	1.0	
Hypotension	ALB	1.0	
Abnormality of the fingernails	KRT9	1.0	
Obesity, severe, 601665 (3)	KCNMA1	1.0	
Congenital diaphragmatic hernia	ALB	1.0	
Pulmonary Embolism	ALB	1.0	
Metastatic malignant neoplasm to brain	KCNMA1	1.0	
Anorexia	ALB	1.0	
Generalized seizures	KCNMA1	1.0	
Abnormal immunoglobulin level	KRT9	1.0	
Acute hepatic failure	ALB	1.0	
Abnormality of B cell physiology	KRT9	1.0	
Abnormality of B cells	KRT9	1.0	
